BIOC logo

Biocept (BIOC) Revenue

Annual Revenue

$25.86 M
-$35.39 M-57.78%

December 31, 2022

Summary

Performance

1-Year Change

-57.78%

3-Year Change

+367.71%

5-Year Change

+410.15%

15-Year Change

+410.15%

BIOC Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.98%
BIOC annual revenue is higher than 39.98% of companies in Healthcare sector

Analysts Estimate

$2.48 M
BIOC annual revenue is currently +942.66% higher than the consensus analysts' forecast

High & Low

All-time High

$61.25 M
BIOC annual revenue is currently -57.78% below its historical high of $61.25 million

3-Year Low

$25.86 M
BIOC annual revenue is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BIOC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BIOC next annual earnings announcement has not yet been scheduled

OtherBIOCprofitabilitymetrics:

Annual EPS

-$56.70
BIOC annual earnings per share is -$56.70

Annual Net Income

-$32.09 M
BIOC annual net profit is -$32.09 million

Annual Operating Profit

-$31.98 M
BIOC annual operating income is -$31.98 million

Annual Gross Profit

-$2.58 M
BIOC annual gross profit is -$2.58 million

Quarterly Revenue

$589.00 K
-$84.00 K-12.48%

June 30, 2023

Summary

Performance

3-Month Change

-12.48%

1-Year Change

-89.88%

3-Year Change

-35.8%

5-Year Change

-28.36%

BIOC Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

15.41%
BIOC quarterly revenue is higher than 15.41% of companies in Healthcare sector

High & Low

All-time High

$19.95 M
BIOC quarterly revenue is currently -97.05% below its historical high of $19.95 million

3-Year Low

-$913.00 K

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOC next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

-$1.96 M
BIOC quarterly gross profit is -$1.96 million

Quarterly Operating Profit

-$6.11 M
BIOC quarterly operating income is -$6.11 million

Quarterly Net Income

-$3.63 M
BIOC quarterly net profit is -$3.63 million

Quarterly EPS

-$3.50
BIOC quarterly earnings per share is -$3.50

TTM Revenue

$1.36 M
-$5.23 M-79.41%

June 30, 2023

Summary

Performance

3-Month Change

-79.41%

1-Year Change

-97.63%

3-Year Change

-76.11%

5-Year Change

-75.47%

BIOC TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

12.21%
BIOC TTM revenue is higher than 12.21% of companies in Healthcare sector

High & Low

All-time High

$65.78 M
BIOC TTM revenue is currently -97.94% below its historical high of $65.78 million

3-Year Low

$1.36 M
BIOC TTM revenue is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOC next earnings announcement has not yet been scheduled

OtherBIOCprofitabilitymetrics:

TTM Gross Profit

-$14.31 M
BIOC TTM gross profit is -$14.31 million

TTM Operating Profit

-$33.16 M
BIOC TTM operating income is -$33.16 million

TTM Net Income

-$30.61 M
BIOC TTM net profit is -$30.61 million

TTM EPS

-$50.90
BIOC TTM earnings per share is -$50.90

BIOC Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-57.8%-89.9%-97.6%
3 y3 years+367.7%-35.8%-76.1%
5 y5 years+410.1%-28.4%-75.5%

BIOC Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-57.8%at low-97.0%+164.5%-97.9%at low
5 y5-year-57.8%+367.7%-97.0%+164.5%-97.9%at low
alltimeall time-57.8%>+9999.0%-97.0%+164.5%-97.9%+5573.6%

Biocept Revenue History

DateAnnualQuarterlyTTM
Jun 2023
-
$589.00 K(-12.5%)
$1.36 M(-79.4%)
Mar 2023
-
$673.00 K(-173.7%)
$6.59 M(-74.5%)
Dec 2022
$25.86 M(-57.8%)
-$913.00 K(-190.7%)
$25.86 M(-36.5%)
Sep 2022
-
$1.01 M(-82.7%)
$40.75 M(-28.8%)
Jun 2022
-
$5.82 M(-70.8%)
$57.21 M(-9.8%)
Mar 2022
-
$19.95 M(+42.7%)
$63.44 M(+3.6%)
Dec 2021
$61.25 M(+123.0%)
$13.98 M(-20.0%)
$61.25 M(-6.9%)
Sep 2021
-
$17.47 M(+45.0%)
$65.78 M(+19.8%)
Jun 2021
-
$12.05 M(-32.2%)
$54.90 M(+25.4%)
Mar 2021
-
$17.76 M(-4.1%)
$43.77 M(+59.4%)
Dec 2020
$27.46 M(+396.7%)
$18.51 M(+181.1%)
$27.46 M(+155.8%)
Sep 2020
-
$6.59 M(+617.8%)
$10.73 M(+89.1%)
Jun 2020
-
$917.50 K(-36.6%)
$5.68 M(-4.6%)
Mar 2020
-
$1.45 M(-18.9%)
$5.95 M(+7.6%)
Dec 2019
$5.53 M(+70.1%)
$1.78 M(+16.6%)
$5.53 M(+20.1%)
Sep 2019
-
$1.53 M(+28.4%)
$4.60 M(+20.0%)
Jun 2019
-
$1.19 M(+16.3%)
$3.84 M(+10.6%)
Mar 2019
-
$1.02 M(+19.2%)
$3.47 M(+6.7%)
Dec 2018
$3.25 M(-35.9%)
$859.50 K(+12.9%)
$3.25 M(-4.0%)
Sep 2018
-
$761.60 K(-7.4%)
$3.39 M(-9.4%)
Jun 2018
-
$822.20 K(+1.9%)
$3.74 M(-10.9%)
Mar 2018
-
$806.90 K(-18.9%)
$4.19 M(-17.3%)
DateAnnualQuarterlyTTM
Dec 2017
$5.07 M(+57.3%)
$995.20 K(-10.5%)
$5.07 M(-5.5%)
Sep 2017
-
$1.11 M(-13.1%)
$5.37 M(+1.2%)
Jun 2017
-
$1.28 M(-24.0%)
$5.30 M(+13.2%)
Mar 2017
-
$1.68 M(+30.3%)
$4.68 M(+45.3%)
Dec 2016
$3.22 M(+428.5%)
$1.29 M(+23.3%)
$3.22 M(+49.9%)
Sep 2016
-
$1.05 M(+58.0%)
$2.15 M(+69.6%)
Jun 2016
-
$662.90 K(+199.4%)
$1.27 M(+86.0%)
Mar 2016
-
$221.40 K(+1.4%)
$681.40 K(+11.7%)
Dec 2015
$609.90 K(+357.2%)
$218.30 K(+32.4%)
$610.00 K(+30.5%)
Sep 2015
-
$164.90 K(+114.7%)
$467.30 K(+49.4%)
Jun 2015
-
$76.80 K(-48.8%)
$312.70 K(+22.6%)
Mar 2015
-
$150.00 K(+98.4%)
$255.10 K(+91.2%)
Dec 2014
$133.40 K(-0.6%)
$75.60 K(+634.0%)
$133.40 K(+74.2%)
Sep 2014
-
$10.30 K(-46.4%)
$76.60 K(-22.0%)
Jun 2014
-
$19.20 K(-32.2%)
$98.20 K(-22.9%)
Mar 2014
-
$28.30 K(+50.5%)
$127.40 K(-5.1%)
Dec 2013
$134.20 K(+22.8%)
$18.80 K(-41.1%)
$134.30 K(-1.5%)
Sep 2013
-
$31.90 K(-34.1%)
$136.40 K(+6.2%)
Jun 2013
-
$48.40 K(+37.5%)
$128.40 K(+60.5%)
Mar 2013
-
$35.20 K(+68.4%)
$80.00 K(+78.6%)
Dec 2012
$109.30 K(+9836.4%)
$20.90 K(-12.6%)
$44.80 K(+87.4%)
Sep 2012
-
$23.90 K
$23.90 K
Dec 2011
$1100.00
-
-

FAQ

  • What is Biocept annual revenue?
  • What is the all time high annual revenue for Biocept?
  • What is Biocept annual revenue year-on-year change?
  • What is Biocept quarterly revenue?
  • What is the all time high quarterly revenue for Biocept?
  • What is Biocept quarterly revenue year-on-year change?
  • What is Biocept TTM revenue?
  • What is the all time high TTM revenue for Biocept?
  • What is Biocept TTM revenue year-on-year change?

What is Biocept annual revenue?

The current annual revenue of BIOC is $25.86 M

What is the all time high annual revenue for Biocept?

Biocept all-time high annual revenue is $61.25 M

What is Biocept annual revenue year-on-year change?

Over the past year, BIOC annual revenue has changed by -$35.39 M (-57.78%)

What is Biocept quarterly revenue?

The current quarterly revenue of BIOC is $589.00 K

What is the all time high quarterly revenue for Biocept?

Biocept all-time high quarterly revenue is $19.95 M

What is Biocept quarterly revenue year-on-year change?

Over the past year, BIOC quarterly revenue has changed by -$5.23 M (-89.88%)

What is Biocept TTM revenue?

The current TTM revenue of BIOC is $1.36 M

What is the all time high TTM revenue for Biocept?

Biocept all-time high TTM revenue is $65.78 M

What is Biocept TTM revenue year-on-year change?

Over the past year, BIOC TTM revenue has changed by -$55.85 M (-97.63%)